11 views | +0 today
Your new post is loading...
Your new post is loading...
Scooped by peter dj!

Market Research Reports & 2014 Competitive Intelligence Data

Market Research Reports & 2014 Competitive Intelligence Data | Analysis |
Find market research reports published recently by global market research publishers in our online library. These latest research reports cover industry trends, market size, share and other data analysis information.
peter dj's insight:

Eloctate (Hemophilia A and B) – Forecast and Market Analysis to 2022

The report “Eloctate (Hemophilia A and B) – Forecast and Market Analysis to 2022″ by GlobalData is now available at

Contact with “Eloctate (Hemophilia A and B) – Forecast and Market Analysis to 2022 “in subject line and your contact details to purchase this report or get your questions answered.

The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. However, the burden on patients and their families to maintain the prophylactic treatment schedule is high, and there is a significant unmet need for new therapies that can reduce the number of weekly prophylactic infusions and alleviate some of this treatment burden.

Buy a copy of this report by GlobalData @ .

Biogen Idec’s long-lasting recombinant Factor VIII candidate Eloctate is under FDA regulatory review for prophylactic and on-demand treatment for hemophilia A patients. Eloctate aims to change the treatment paradigm by allowing patients to adopt a prophylactic dosing schedule with increased time between infusions.


Overview of Hemophilia A and B, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.Detailed information on Eloctate including product description, safety and efficacy profiles as well as a SWOT analysis.Sales forecast for Eloctate for the top nine countries from 2012 to 2022.Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, Argentina and China.

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust returnStay ahead of the competition by understanding the changing competitive landscape for Hemophilia A and BEffectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potentialMake more informed business decisions from insightful and in-depth analysis of Eloctate performanceObtain sales forecast for Eloctate from 2012-2022 in top nine countries (the US, France, Germany, Italy, Spain, the UK, Japan, Argentina and China)

Complete report spread across 59 pages available @ .

Read more on “Eloctate (Hemophilia A and B) – Forecast and Market Analysis to 2022” report below.

Table of Contents

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 7

2 Introduction 8

2.1 Catalyst 8

2.2 Related Reports 9

2.3 Upcoming Related Reports 11

3 Disease Overview 12

3.1 Etiology and Pathophysiology 12

3.1.1 Etiology 12

3.1.2 Pathophysiology 13

3.1.3 Prognosis and Quality of Life 15

3.2 Symptoms 16

3.2.1 Hemophilia A and B 16

3.2.2 Inhibitors 17

4 Disease Management 18

4.1 Treatment Overview 18

4.1.1 Hemophilia A and B Diagnosis 19

4.1.2 Hemophilia A and B Treatment 19

4.1.3 Inhibitors Diagnosis 21

4.1.4 Inhibitors Treatment 21

5 Competitive Assessment 23

5.1 Overview 23

5.2 Strategic Competitive Assessment 24

6 Opportunity and Unmet Need 28

6.1 Overview 28

6.2 Opportunities Analysis 29

6.2.1 Longer-Lasting Recombinant Factors to Reduce the Frequency of Prophylactic Injections 29

6.2.2 Lower-Cost Recombinant Replacement Therapies 30

6.2.3 Lower Risk of Inhibitor Formation in Previously Untreated Patients 31

6.2.4 More Convenient Drug Administration 31

6.2.5 Oral Formulation of Recombinant Replacement Therapies 32

6.3 Unmet Needs Gap Analysis 32

6.3.1 Long-Acting FVIII Replacement Therapies 32

6.3.2 Gene Therapy Treatments for Hemophilia A and B 33

7 Pipeline Assessment 34

7.1 Overview 34

7.2 Promising Drugs in Clinical Development - Hemophilia A 34

7.3 Promising Drugs in Clinical Development - Hemophilia B 36

7.4 Promising Drugs in Clinical Development - Hemophilia A and B Patients with Inhibitors 38

8 Eloctate (rFVIII-Fc) 39

8.1 Overview 39

8.2 Efficacy 40

8.3 Safety 41

8.4 Dosing and Formulation 41

8.5 Potential Clinical Positioning 42

8.6 Potential Commercial Positioning 43

8.7 Pricing and Reimbursement 43

8.8 SWOT Analysis 44

For further information on “Eloctate (Hemophilia A and B) – Forecast and Market Analysis to 2022” report OR for any other business research / market intelligence need on the ‘Hematology Therapeutics’ market : .

Contact: / Call +1 888 391 5441.

Read More @ .


No comment yet.
Scooped by peter dj!

Active & Intelligent Packaging to 2017 : ReportsnReports

Active & Intelligent Packaging to 2017 : ReportsnReports | Analysis |
[337 Pages Report] Check for Discount on Active & Intelligent Packaging to 2017 report by Freedonia Group. This study analyzes the US active and intelligent packaging...
peter dj's insight:

Active & Intelligent Packaging to 2017

Order report “Active & Intelligent Packaging to 2017” by calling at +1 888 391 5441 OR send an email on  with Active & Intelligent Packaging to 2017 in subject line and your contact details.           

This study analyzes the US active and intelligent packaging industry. It presents historical demand data (2002, 2007, 2012) and forecasts for 2017 and 2022 by product (e.g., gas scavengers, corrosion control packaging, moisture control packaging, susceptor packaging, time-temperature indicators) and market (e.g., food, beverages, primary metals, pharmaceuticals, motor vehicles, electronics). The study also considers market environment factors, details industry structure, evaluates company market share and profiles industry players.

Buy a copy of report @ .

US demand to reach $3.5 billion in 2017

Demand for active and intelligent pack-aging is projected to reach $3.5 billion in 2017, fueled by the development of new generations of products with increased functionality and the expanded availability of lower cost products. Growth for intelligent packaging will be significantly faster than that of active packaging and will be propelled by rapid advances for newer and emerging technologies such as quick response (QR) and other mobile marketing codes and printed electronics on packaging. Gains will also be aided by greater use of time-temperature indicator labels due to the availability of less costly product types as well as growing requirements with temperature-sensitive drugs and food safety regulations calling for increased track and trace capabilities.


Gas scavengers to remain key product type

Gas scavengers were the leading active packaging product type in 2012. Growth will outpace the active packaging average through 2017 based on rising demand for barrier polyethylene terephthalate (PET) bottles in single-serving sizes. Advances will also be supported by a continued favorable outlook for packaged organic foods and the removal of trans fats from many types of processed and other foods, necessitating the need for oxygen absorbers in extending shelf life.

Moisture control, corrosion control, and susceptor packaging demand will expand more slowly based on the presence of more mature product types and applications. Corrosion control packaging demand will accelerate, aided by height-ened domestic and reshored US manufacturing activity following recent declines.

Complete report of 337 Pages is available @ .

Pharmaceuticals to be fastest growing market

Food and beverages were the two largest markets for active and intelligent packaging in 2012, together accounting for 65 percent of demand. Advances in food uses will be based on heightened requirements for longer shelf life for processed foods and packaged fresh foods and the growing importance of food safety following outbreaks of foodborne illnesses. Additionally, robust advances for intelligent packaging will be driven by the proliferation of smart - phones and tablets, which can read quick response and other advanced barcodes on packaging. Near field communication-enabled devices will achieve a growing presence over the next several years and will provide further gains as the technology is simpler to use than QR codes.

Beverage market demand will be driven by greater use of intelligent packaging on beverage containers and labels, including color indicating features, smartphone-enabled barcodes, and time-temperature indicators. Oxygen scavenger increases will be driven by the greater cost- competitiveness of monolayer oxygen scavenging systems compared to multilayer systems along with rising use of single-serving PET bottles.

Pharmaceuticals will be the fastest growing market for active and intelligent packaging through 2017, fueled by the growing health care needs of the aging US population, an increased prevalence of chronic diseases, and the expanding presence of high value, temperature-sensitive biotechnology drugs in the product mix. In addition, technology improvements will result in more affordable pricing for many intelligent packaging products. The increased prevalence of drugs with high moisture sensitivity will boost demand for moisture control packaging.

Buy a copy of report @ .


Company Profiles

Profiles over 40 US industry players such as Clariant International, Graphic Packaging, Multisorb Technologies,Reynolds Group and Sealed Air

Additional Information

This study examines the market for active and intelligent packaging in the United States. Active packaging is broadly defined as packaging that performs a function beyond the protection and identification of its contents. Intelligent packaging refers to packaging technology that provides external data and/or relays information relative to the status of the contents. Product segments covered include gas scavengers, corrosion control packaging, moisture control packaging, susceptor packaging, other active packaging (e.g., antimicrobial packaging, flavor and fragrance control packaging, and self venting and air-releasing packaging), color indicating packaging, time temperature indicators (TTIs), and other intelligent packaging (e.g., pharmaceutical compliance packaging, assistive packaging, and smart phone enabled interactive packaging). Markets for these products include food, beverages, pharmaceuticals, primary metals, motor vehicles, electronics, and other (e.g., industrial machinery, military equipment and supplies, diagnostic and medical equipment, aerospace products, cosmetics and toiletries, cut flowers, and metal packaging). Excluded from this study are radio frequency identification (RFID) tags, data loggers, readers, software, and similar products serving security and supply chain tracking and monitoring functions. However, RFID tags used for diagnostic or informational functions are included. Also excluded are TTIs for nonpackaging uses, such as temperature testing labels for industrial equipment.

Historical data (2002, 2007, 2012) and forecasts for 2017 and 2022 are provided for active and intelligent packaging demand (i.e., consumption) in current dollars (including inflation). “Demand” (or sales, apparent consumption) is defined as all shipments from US plants, plus imports, minus exports. The term “shipment” includes production from all US manufacturing establishments that is then shipped to both US and foreign markets. In addition, the key strategic variables affecting the active and intelligent packaging industry are discussed, and the industry’s key players are identified and profiled. US market share is also presented. The entire study is framed within the context of overall economic conditions, as well as developments and technologies influencing the active and intelligent packaging industry and its end users.

Buy a copy of report @ .

Table of Contents

Introduction IX

I. Executive Summary 1

II. Market Environment 4

General 4

Macroeconomic Outlook 5

Demographic Trends 8

Consumer Income & Spending Trends 12

Manufacturing Outlook 15

Packaging Overview 19

Paper 22

Plastic 22

Metal 23

Glass & Wood 24

Pricing Trends 25

Environmental & Regulatory Considerations 28

International Activity & Foreign Trade 31

III. Products 34

General 34

Active Packaging 36

Gas Scavengers 40

Oxygen 42

Types 47

Producers 52

Ethylene 56

Carbon Dioxide 58

Corrosion Control Packaging 60

Volatile Corrosion Inhibitors 62

Scavengers 66

Moisture Control Packaging 68

Desiccants 70

Silica Gel 74

Clay 75

Other Desiccants 77

Other Moisture Control Packaging 78

Susceptor Packaging 82

Other Active Packaging 85

Antimicrobial Packaging 86

Flavor & Fragrance Control Packaging 89

Self-Venting Packaging 92

All Other Active Packaging 95

Intelligent Packaging 98

Color Indicating Packaging 101

Time-Temperature Indicators 104

Markets 108

Producers 109

Users 113

Other 114

Food Intelligent Packaging 115

Pharmaceutical Intelligent Packaging 119

Beverage & All Other Intelligent Packaging 125

Contact / Call +1 888 391 5441 for further information on “Active & Intelligent Packaging to 2017” report OR for any other market research and intelligence needs you may have for your business.

Read More @


No comment yet.